glp 1 for dementia Glucagon like peptide-1 (GLP-1) likes Alzheimer's disease NEW STUDY: GLP-1 meds slash

Davies, M.J., et al., CagrilintideSemaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

The 72-hour minimum rule The prescribing information for tirzepatide (Mounjaro and Zepbound) states clearly: if you want to change the day of the week you take your injection, you must maintain at least 72 hours (three days) between doses

Regular check-ins help ensure the chosen duration aligns with your evolving health priorities

They need steady blood sugar control over time

Preclinical combination studies confirm that simultaneous GLP-1R and GIPR activation outperforms either receptor alone for weight reduction and glycemic control

According to FDA communications, the agency has distinguished between mass-marketed compounded products and patient-specific compounding performed under Section 503A of the FD&C Act, which may remain permissible in narrow circumstances where a patient's medical needs cannot be met by an FDA-approved drug